Velpatasvir + Sofosbuvir Suppliers & Bulk Manufacturers

Available Forms: Tablet

Available Strengths: Sofosbuvir - 400 mg + Velpatasvir - 100 mg

Reference Brands: Epclusa(US & EU)

Category: Anti Viral

Velpatasvir + Sofosbuvir is available in Tablet and strengths such as Sofosbuvir - 400 mg + Velpatasvir - 100 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Velpatasvir + Sofosbuvir is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Velpatasvir + Sofosbuvir can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description: Epclusa is a once-daily, fixed-dose combination of Sofosbuvir 400 mg and Velpatasvir 100 mg, approved by the FDA and EMA for the treatment of chronic hepatitis C virus (HCV) infection across all six genotypes. This pan-genotypic regimen offers a high sustained virologic response (SVR) rate of over 95%, making it a preferred choice for both treatment-naïve and previously treated patients. Epclusa is suitable for use with or without ribavirin, depending on liver disease status. Its simplified, one-pill-daily format improves adherence and outcomes. It is also available for pediatric patients aged 3 years and older in tablet and granule forms.